TRUADVICE’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$868K Sell
5,893
-659
-10% -$109K 0.34% 86
2023
Q2
$1.13M Buy
6,552
+378
+6% +$61K 0.41% 68
2023
Q1
$1.01M Buy
6,174
+1,919
+45% +$310K 0.4% 67
2022
Q4
$733K Buy
4,255
+470
+12% +$81.2K 0.39% 49
2022
Q3
$655K Buy
3,785
+501
+15% +$84.8K 0.37% 51
2022
Q2
$564K Buy
3,284
+532
+19% +$94.8K 0.3% 65
2022
Q1
$492K Buy
2,752
+326
+13% +$55.5K 0.27% 70
2021
Q4
$416K Buy
2,426
+5
+0.2% +$819 0.39% 74
2021
Q3
$394K Sell
2,421
-3,745
-61% -$639K 0.36% 77
2021
Q2
$1.06M Buy
6,166
+663
+12% +$110K 0.23% 102
2021
Q1
$904K Sell
5,503
-1,080
-16% -$175K 0.27% 80
2020
Q4
$1.1M Buy
6,583
+1,272
+24% +$188K 0.34% 72
2020
Q3
$785K Buy
+5,311
New +$786K 0.32% 74

Other funds holding JNJ

TRUADVICE's JNJ Position: Q3 2023 in Review

TRUADVICE reduced its Johnson & Johnson (JNJ) stake by 10% in Q3 2023, selling an estimated $109K and leaving 5,893 shares worth $868K. The position accounts for 0.34% of the portfolio, ranked #86.

TRUADVICE first reported a position in JNJ in Q3 2020 and has held it in 13 quarters since. The position peaked at $1.13M in Q2 2023. 3,678 funds tracked by Wall St. Rank hold JNJ as of Q3 2023.

  • TRUADVICE held 5,893 shares of Johnson & Johnson worth $868K as of Q3 2023.
  • TRUADVICE sold 659 Johnson & Johnson shares in Q3 2023, an estimated $109K.
  • Johnson & Johnson made up 0.34% of TRUADVICE's portfolio in Q3 2023, its #86 holding.
  • TRUADVICE first reported a position in Johnson & Johnson in Q3 2020 and has held it in 13 quarters since.
  • TRUADVICE's Johnson & Johnson position peaked at $1.13M in Q2 2023.
  • 3,678 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2023.

Based on TRUADVICE's 13F filing for Q3 2023, filed 13 Nov 2023.